Revenue segments as reported by the company.

Total Oral, Personal and Home Care

Pet Nutrition

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative expenses

Other (income) expense, net

Goodwill and indefinite-lived intangible impairment charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Colgate-Palmolive

Ajax is a brand of cleaning products of Colgate-Palmolive.

Ajax

Speed Stick is a brand of deodorant/antiperspirant that, as the name suggests, comes in stick form. The product is owned by its parent company, Colgate-Palmolive. It was formerly known as "Mennen Speed Stick" prior to Colgate-Palmolive's purchase of The Mennen Company. Currently, the products feature the words "by Mennen" in a small font on the label. Speed Stick comes in both deodorant and antiperspirant forms. Speed Stick is both a sponsor and the official antiperspirant of the NHL.

Speed Stick

Irish Spring is the brand name of a deodorant soap, first marketed by the Colgate-Palmolive company in 1970. Irish Spring currently has nine variants.

Irish Spring

Mennen is a brand owned in most parts of the world by the Colgate-Palmolive Company. Its most notable product, Mennen Speed Stick, with its fougère perfume and green wide stick, was the market leader among deodorants and antiperspirants for men for many years.

Mennen

Softsoap is the trade name of Colgate-Palmolive's liquid hand soap and body wash.

Softsoap

Tom's of Maine is a brand name and manufacturing company of personal care products with only natural ingredients and a majority-owned subsidiary of Colgate-Palmolive since 2006. The company's products are intentionally made without ingredients that are chemically derived, environmentally damaging, or are tested on animals. While most of its products are vegan, some contain propolis and/or beeswax sourced from bees.

Tom's of Maine

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Colgate-Palmolive reports robust Q4 growth and eyes future opportunities

Colgate-Palmolive's Q4 2022 earnings call highlighted strong organic sales growth and positive outlook for 2023.
The company faces challenges such as macroeconomic volatility, raw material costs, and cash flow concerns.
Opportunities lie in investments for future growth, margin improvement, and sustaining shareholder value.
Overall, Colgate-Palmolive remains focused on innovation, market share strength, and long-term success.

Colgate-Palmolive reports strong Q1 performance amidst inflation challenges

Colgate-Palmolive's Q1 performance was strong, with a focus on driving growth and improving margins. Despite challenges like inflation and competitive pressures, the company is leveraging strengths in innovation and brand equity to capitalize on opportunities in emerging markets and non-measured channels.

Colgate-Palmolive reports robust Q2 results and eyes emerging markets

Colgate-Palmolive's Q2 earnings call highlighted strong performance, balanced growth, and strategic focus on restoring gross margins.
The company remains confident in its strategies for consistent profitable growth and increasing shareholder value.
Opportunities in emerging markets and digital transformation are key drivers of future growth and competitiveness.

Colgate-Palmolive posts strong Q3 results, eyes sustained profitability and growth

Colgate-Palmolive's Q3 earnings call reflects a robust performance with a focus on sustainable profit growth and margin expansion. The company's strategic initiatives to address challenges and capitalize on opportunities position it well for future growth and market leadership.

Colgate-Palmolive reports robust performance in 2023, eyes balanced growth

Colgate-Palmolive's Q4 2023 earnings call highlighted strong performance, strategic focus on balanced growth, and opportunities for innovation-driven market expansion. The company faces challenges in managing market volatility and inflationary pressures but is well-positioned for growth. Leveraging strengths in market share, innovation, and strategic investments, Colgate-Palmolive aims for consistent earnings growth in 2024.

Colgate-Palmolive reports resilient Q1 performance and eyes global expansion

Colgate-Palmolive's Q1 2024 performance reflects resilience and strategic growth initiatives despite operational challenges.
Strong balance sheet, focus on innovation, and market expansion strategies position the company for sustainable growth.
Opportunities in Latin America, Europe, and emerging markets offer avenues for continued growth and market share expansion.
Emphasis on digital execution and value creation through innovation drive competitive advantage and market differentiation.

Colgate-Palmolive reports solid Q2 results, focuses on growth strategies

Colgate-Palmolive's Q2 call highlighted a strong performance, strategic focus on growth drivers, and challenges in pricing and consumer behavior. The company aims to leverage its strengths in innovation and brand presence to seize long-term opportunities.

Colgate-Palmolive reports robust Q3 results, eyes sustained growth strategies

Colgate-Palmolive's Q3 performance reflects a resilient business model with a strong focus on innovation and strategic investments.
Despite challenges in North America, the company's overall growth trajectory remains positive, driven by volume expansion and market adaptability.
Management's emphasis on sustained growth through strategic investments underscores a forward-looking approach to navigating market dynamics.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Higher raw material and SG&A costs, and adverse currency are likely to get reflected in Colgate's (CL) third-quarter margins and earnings. However, pricing gains and innovation might have offset woes.

Things You Need to Know Before Colgate's (CL) Q3 Earnings

Cisco Systems

Eli Lilly

These big stock charts highlight three value plays left behind in the market's shift away from growth stocks.
The post 3 Big Stock Charts for Thursday: Cisco Systems, Eli Lilly, and Colgate-Palmolive appeared first on InvestorPlace.

3 Big Stock Charts for Thursday: Cisco Systems, Eli Lilly, and Colgate-Palmolive

Hormel Foods

Hershey

McCormick

PepsiCo

Molson Coors Brewing

With interest rates going down, investors are looking for safe dividend stocks to buy. Food and beverage companies are great options.

7 Dividend Stocks to Buy (With Brands You Can Find In Your Kitchen)

AutoZone

Comcast

Costco

Dunkin' Brands

Home Depot

Walmart

In the Lead: Goldman identifies stocks that tend to outperform in challenging macro environments.

7 'Stable Growth' Stocks That Can Lead as Economy Slows

Coca-Cola

Procter & Gamble

A combination of falling interest rates and investors' thirst for defensive assets has made the consumer staples one of 2019's best-performing groups.

Why It Might Be Time For This Obscure Geared ETF

Colgate (CL) is grappling with weak margin trend and adverse impacts of currency. Nevertheless, its accelerated investments in brands, higher pricing and strong innovations bode well for growth.

Colgate's (CL) Growth Efforts on Track, Cost Woes Persist

Kimberly-Clark

Colgate-Palmolive (NYSE: CL) and Kimberly Clark are two major players in the consumer products segment, with Colgate having a bigger global presence of the two. Colgate’s Revenue comes mainly from Oral Care Products, whereas for Kimberly Clark, Personal Care (mainly Baby Care) and Consumer Tissue.

Comparing Revenue And Key Metrics For The Two Consumer Giants, Colgate-Palmolive And Kimberly Clark

Is  (CL) Outperforming Other Consumer Staples Stocks This Year?

Has Colgate-Palmolive (CL) Outpaced Other Consumer Staples Stocks This Year?

In a world of trade wars, stock market sell-offs and inverted yield curves (even negative yields), investors also have to deal with a slowdown in earnings and economic numbers.

Colgate-Palmolive May Be Both Cheap and Expensive for a Defensive Stock

Abbott Labs

Automatic Data Processing

Becton, Dickinson and Co.

Con Ed

What makes these stocks so resilient? And how did they perform during the last crisis?

Top 5 Recession Stocks

Colgate (CL) is benefiting from higher pricing, strong innovation and expansion efforts. Moreover, the company's savings programs are delivering impressive result.

Colgate (CL) Displays a Solid Run-Up of More Than 20% YTD

Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock?

Colgate-Palmolive (CL) Up 0.4% Since Last Earnings Report: Can It Continue?

Colgate-Palmolive Co  is warning Venezuelans not buy fake versions of its toothpaste brands, leading local authorities to issue a health warning, as demand for imported products in Venezuela's dysfunctional economy encourages the spread of knock-off goods.

Colgate warns Venezuelans not to buy fake imported toothpaste brands

Colgate Palmolive‘s (NYSE: CL), share price has seen a steady rise over this year, primarily due to the company beating market consensus in revenue and earnings for Q4 2018 and Q1 2019. But for Q2 2019, results declared recently by the company missed market consensus in revenue and earnings.

Do JP Morgan and Morgan Stanley Agree On Colgate-Palmolive's Target Price?

CFO of Colgate-palmolive Co (30-Year Financial, Insider Trades) Henning I Jakobsen (insider trades) sold 33,854 shares of CL on 07/31/2019 at an average price of $73.45 a share.

Colgate-palmolive Co (CL) CFO Henning I Jakobsen Sold $2.5 million of Shares

Colgate-Palmolive (CL) has continued to show sales growth even after raising product prices.

Colgate-Palmolive: I Underestimated The Stock's Potential

Colgate-Palmolive Company (CL) CEO Noel Wallace on Q2 2019 Results - Earnings Call Transcript

Colgate (CL) posts lower-than-expected second-quarter 2019 results. Foreign currency translations remain a major headwind in the quarter.

Colgate (CL) Q2 Earnings & Sales Miss Estimates, Decline Y/Y

Colgate-Palmolive (CL) delivered earnings and revenue surprises of -1.37% and -0.02%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Colgate-Palmolive (CL) Lags Q2 Earnings and Revenue Estimates

Colgate-Palmolive Co. CL, +0.91% reported second-quarter of $586 million, or 68 cents per share, down from $637 million, or 73 cents per share, in 2018.

Colgate-Palmolive reports earnings in line with expectations, revenue just misses

Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Colgate-Palmolive (CL) Might Surprise This Earnings Season

Alexion Pharma

Chipotle

PayPal

Visa

It will be prudent to invest in stocks that are likely to beat earnings estimates in the second quarter this week.

Buy 5 High-Flying Stocks Ahead of Q2 Earnings This Week

Colgate is acquiring Laboratoires Filorga for $1.7 billion. Does this deal fit within the company's growth strategy?

Colgate Makes Its Largest Acquisition in Over 20 Years

Estee Lauder

Mondelez

Altria

Philip Morris

These companies dominate one of investors' favorite business niches.

The 10 Biggest Consumer Staples Stocks

Colgate's (CL) growth efforts indicate that it will likely retain the robust bottom-line surprise trend. However, soft margins and adverse currency may be deterrents.

News for Colgate-Palmolive Stock (CL)